Additionally, CCL8 dramatically activates ERK1/2 phosphorylation in GBM cells, and blocking GAM-secreted CCL8 using neutralized antibodies significantly decreases the invasion of glioma cells [104]. This evidence concerns the gene CCL8 and central nervous system cancer.